Cornelia Quadt
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
- Heat shock proteins research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 15
- Heat shock proteins research 9
-
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Michael Rugaard Jensen (8 shared papers)Dejan Juric (7 shared papers)Douglas Bootle (6 shared papers)Jordi A. Rodon (8 shared papers)Howard A. Burris (7 shared papers)David Demanse (8 shared papers)José Baselga (5 shared papers)Mark Ross Middleton (3 shared papers)
- Journals
- Blood (3 papers)Annals of Oncology (3 papers)Molecular Cancer Therapeutics (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Nature (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Cornelia Quadt
34 papers receiving 2.8k citations
Cornelia Quadt's Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 342
- Molecular Biology 1.4k
- Oncology 360
- Pulmonary and Respiratory Medicine 400
- Radiology, Nuclear Medicine and Imaging 237
Countries citing papers authored by Cornelia Quadt
This map shows the geographic impact of Cornelia Quadt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Quadt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Quadt more than expected).
Fields of papers citing papers by Cornelia Quadt
This network shows the impact of papers produced by Cornelia Quadt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Quadt. The network helps show where Cornelia Quadt may publish in the future.
Co-authors
The 25 scholars most cited alongside Cornelia Quadt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 496 | |
| 2 | 2018 | 358 | |
| 3 | 2013 | 287 | |
| 4 | 2018 | 216 | |
| 5 | 2016 | 208 | |
| 6 | 2008 | 204 | |
| 7 | 2013 | 137 | |
| 8 | 2010 | 101 | |
| 9 | 2005 | 86 | |
| 10 | 2009 | 84 | |
| 11 | 2014 | 80 | |
| 12 | Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers Hit paper breakdown → | 2024 | 79 |
| 13 | 2008 | 75 | |
| 14 | 2013 | 66 | |
| 15 | 2013 | 59 | |
| 16 | 2006 | 45 | |
| 17 | 2018 | 45 | |
| 18 | 2018 | 42 | |
| 19 | 2009 | 39 | |
| 20 | BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study | 2012 | 37 |
About Cornelia Quadt
Cornelia Quadt is a scholar working on Molecular Biology, Hematology, Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 2.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (15 papers), Heat shock proteins research (9 papers), Multiple Myeloma Research and Treatments (4 papers), Advanced Breast Cancer Therapies (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Genetic factors in colorectal cancer (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (342 citations), Molecular Biology (1.4k citations), Oncology (360 citations), Pulmonary and Respiratory Medicine (400 citations) and Radiology, Nuclear Medicine and Imaging (237 citations). Cornelia Quadt has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Michael Rugaard Jensen, Dejan Juric, Douglas Bootle, Jordi A. Rodon, Howard A. Burris, David Demanse, José Baselga, Mark Ross Middleton, Carlos Garcı́a-Echeverrı́a and Martin Schüler. Their work appears in journals such as Blood, Annals of Oncology, Molecular Cancer Therapeutics, Cancer Chemotherapy and Pharmacology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.